Accounting for B cell behaviour and sampling bias yields a superior predictor of anti-PD-L1 response in bladder cancer
I. A. Dyugay, D. K. Lukyanov, M. A. Turchaninova, A. R. Zaretsky, O. A. Khalmurzaev, V. B. Matveev, M. M. Shugay, P. V. Shelyakin, D. M. Chudakov
The paper develops a RNA-Seq-based predictor of anti-PD-L1 response in bladder cancer by integrating B, NK, and T cell components and accounting for sampling bias.
bioRxiv · Mar 4, 2021 · PreprintImmunology